Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model.
Saved in:
| Title: | Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model. |
|---|---|
| Authors: | Leuzy A; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.; Critical Path for Alzheimer's Disease (CPAD) Consortium, Critical Path Institute, Tucson, Arizona, USA.; Enigma Biomedical Group, Knoxville, Tennessee, USA., Raket LL; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.; Eli Lilly and Company, Indianapolis, Indiana, USA., Villemagne VL; Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.; Florey Department of Neuroscience, University of Melbourne, Parkville, Victoria, Australia.; Department of Molecular Imaging & Therapy, Austin Health, Heidelberg, Victoria, Australia., Klein G; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Tonietto M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Olafson E; Clinical Imaging Group, Genentech, Inc., South San Francisco, California, USA., Baker S; Lawrence Berkeley National Laboratory, Berkeley, California, USA., Saad ZS; Janssen Research & Development, Merryfield Row San Diego, California, USA., Bullich S; Life Molecular Imaging GmbH, Berlin, Germany., Lopresti B; Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Bohorquez SS; Clinical Imaging Group, Genentech, Inc., South San Francisco, California, USA., Boada M; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Av. de Monforte de Lemos, Madrid, Spain., Betthauser TJ; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Medicine Division of Geriatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Medical Physics, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, Wisconsin, USA., Charil A; Eisai, Inc., Nutley, New Jersey, USA., Collins EC; Eli Lilly and Company, Indianapolis, Indiana, USA., Collins JA; Biogen, Cambridge, Massachusetts, USA., Cullen N; Critical Path for Alzheimer's Disease (CPAD) Consortium, Critical Path Institute, Tucson, Arizona, USA., Gunn RN; Invicro, Hammersmith Hospital, London, UK.; Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK., Higuchi M; Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Inage-ku, Chiba-shi, Chiba, Japan., Hostetler E; Merck & Co., Inc, West Point, Pennsylvania, USA., Hutchison RM; Biogen, Cambridge, Massachusetts, USA., Iaccarino L; Eli Lilly and Company, Indianapolis, Indiana, USA., Insel PS; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, California, USA., Irizarry MC; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA., Jack CR Jr; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA., Jagust WJ; University of California Berkeley, Lawrence Berkeley National Laboratory, Berkeley, California, USA., Johnson KA; Harvard Medical School, Department of Radiology, Boston, Minnesota, USA.; Gordon Center for Medical Imaging, Massachusetts General Hospital, Boston, Minnesota, USA., Johnson SC; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Medicine Division of Geriatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Medical Physics, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, Wisconsin, USA., Karten Y; Critical Path for Alzheimer's Disease (CPAD) Consortium, Critical Path Institute, Tucson, Arizona, USA., Marquié M; Department of Medicine Division of Geriatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Medical Physics, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, Wisconsin, USA., Mathotaarachchi S; Enigma Biomedical Group, Knoxville, Tennessee, USA., Mintun MA; Eli Lilly and Company, Indianapolis, Indiana, USA., Ossenkoppele R; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.; Amsterdam University Medical Center, Neuroscience Campus Amsterdam, Alzheimercenter, HZ Amsterdam, the Netherlands., Pappas I; Department of Psychology, Helen Wills Neuroscience Institute, University of California, Berkeley, California, USA.; Department of Neurology, VA Northern California Health Care System, Martinez, California, USA., Petersen RC; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Rabinovici GD; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, California, USA.; Department of Radiology & Biomedical Imaging, University of California, San Francisco, California, USA., Rosa-Neto P; Translational Neuroimaging Laboratory, Department of Neurology and Neurosurgery, Faculty of Medicine, The McGill University Research Centre for Studies in Aging, McGill University, Verdun, Quebec, Canada.; Montreal Neurological Institute, McGill University, Montréal, Québec, Canada., Schwarz CG; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA., Smith R; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.; Department of Neurology, Skåne University Hospital, Lund, Sweden., Stephens AW; Life Molecular Imaging GmbH, Berlin, Germany., Whittington A; Invicro, Hammersmith Hospital, London, UK., Carrillo MC; Alzheimer's Association, Chicago, Illinois, USA., Pontecorvo MJ; Eli Lilly and Company, Indianapolis, Indiana, USA., Haeberlein SB; Enigma Biomedical Group, Knoxville, Tennessee, USA., Dunn B; Senior advisor to CPAD Consortium, Critical Path Institute, Tucson, Arizona, USA., Kolb HC; Enigma Biomedical Group, Knoxville, Tennessee, USA., Sivakumaran S; Critical Path for Alzheimer's Disease (CPAD) Consortium, Critical Path Institute, Tucson, Arizona, USA., Rowe CC; Florey Department of Neuroscience, University of Melbourne, Parkville, Victoria, Australia.; Department of Molecular Imaging & Therapy, Austin Health, Heidelberg, Victoria, Australia.; The Australian Dementia Network (ADNeT), The University of Melbourne, Parkville, Victoria, Australia., Hansson O; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.; Memory Clinic, Skåne University Hospital, Malmö, Sweden., Doré V; Department of Molecular Imaging & Therapy, Austin Health, Heidelberg, Victoria, Australia.; Health and Biosecurity Flagship, The Australian eHealth Research Centre, CSIRO, Parkville, Victoria, Australia. |
| Source: | Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2024 Sep; Vol. 20 (9), pp. 5833-5848. Date of Electronic Publication: 2024 Jul 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
